Aijie Xin Selected Research

anordrin (AF 53)

1/2017

Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aijie Xin Research Topics

Disease

2	Inflammation (Inflammations) 04/2013 - 04/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2022
1	Androgen-Insensitivity Syndrome (Testicular Feminization) 06/2022
1	Disorders of Sex Development (Intersexuality) 06/2022
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Endometrial Neoplasms (Endometrial Cancer) 01/2017
1	Adenocarcinoma 10/2016
1	Male Infertility (Male Sterility) 02/2016
1	Infertility (Sterility) 02/2016
1	Septic Shock (Toxic Shock Syndrome) 04/2013

Drug/Important Bio-Agent (IBA)

2	Peptides (Polypeptides)IBA 04/2013 - 04/2013
1	Androgen Receptors (Androgen Receptor)IBA 06/2022
1	Estrogens (Estrogen)FDA Link 01/2017
1	Estrogen ReceptorsIBA 01/2017
1	Tamoxifen FDA LinkGeneric 01/2017
1	anordrin (AF 53)IBA 01/2017
1	IntegrinsIBA 10/2016
1	LectinsIBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 02/2016
1	DefensinsIBA 04/2013
1	Therapeutic UsesIBA 04/2013
1	Antimicrobial PeptidesIBA 04/2013
1	LipopolysaccharidesIBA 04/2013
1	beta-DefensinsIBA 04/2013
1	p38 Mitogen-Activated Protein KinasesIBA 04/2013